| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| No holdings reported for quarter Q3 2019 | ||||||||
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| HORIZON THERAPEUTICS PUB LTD | 16 | Q3 2023 | 3.1% |
| LILLY ELI & CO | 16 | Q3 2023 | 2.5% |
| TELEFLEX INCORPORATED | 16 | Q3 2023 | 1.1% |
| ICU MED INC | 16 | Q3 2023 | 0.9% |
| VISHAY INTERTECHNOLOGY INC | 15 | Q3 2023 | 1.9% |
| ARROW ELECTRS INC | 15 | Q3 2023 | 1.8% |
| JOHNSON & JOHNSON | 14 | Q3 2023 | 4.1% |
| REGENERON PHARMACEUTICALS | 14 | Q3 2023 | 2.0% |
| ZIMMER BIOMET HOLDINGS INC | 14 | Q3 2023 | 1.2% |
| VIAVI SOLUTIONS INC | 14 | Q3 2023 | 1.0% |
View Woodline Partners LP's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Ascendant Digital Acquisition Corp. III | February 10, 2023 | 1,286,000 | 4.3% |
| Senti Biosciences, Inc. | February 10, 2023 | ? | ? |
| Dynamics Special Purpose Corp. | February 11, 2022 | 2,000,000 | 8.4% |
| Eledon Pharmaceuticals, Inc. | February 11, 2022 | 685,273 | 4.8% |
| MARKETWISE, INC.Sold out | February 11, 2022 | 0 | 0.0% |
| Ascendant Digital Acquisition Corp. | February 16, 2021 | 4,008,770 | 9.7% |
| Eledon Pharmaceuticals, Inc. | February 16, 2021 | 814,756 | 5.4% |
View Woodline Partners LP's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-12 |
| SC 13G/A | 2024-02-12 |
| SC 13G | 2024-02-12 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-14 |
| SC 13G/A | 2023-02-10 |
| SC 13G/A | 2023-02-10 |
View Woodline Partners LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.